Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy

23 Aug 2021

Abstract excerpt

In recent decades, adoptive cell transfer and checkpoint blockade therapies have revolutionized immunotherapeutic approaches to cancer treatment. Advances in whole exome/genome sequencing and bioinformatic detection of tumour-specific genetic variations and the amino acid sequence alterations they induce have revealed that T cell mediated anti-tumour immunity is substantially directed at mutated peptide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34439399
DOI: 10.3390/cancers13164245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Targeting of Mutant Peptide Neoantigens in Cancer ImmunotherapyPMID 34439399Read ↗

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and ImmunotherapySemantic proximity Read ↗

New emerging targets in cancer immunotherapy: the role of neoantigensSemantic proximity Read ↗

Neoantigen-based cancer immunotherapySemantic proximity Read ↗

Tumor neoantigens: building a framework for personalized cancer immunotherapy.Semantic proximity Read ↗

The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives.Semantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

The Role of Neoantigens in Cancer ImmunotherapySemantic proximity Read ↗

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

Characterizing neoantigens for personalized cancer immunotherapy.Semantic proximity Read ↗

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.Semantic proximity Read ↗

Cancer Neoantigen Vaccines Emerge Efficacious.Semantic proximity Read ↗

Neoantigens: The Novel Precision Cancer ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.